<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><title>SEC FORM 
            3/A</title><style type="text/css">
              .FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif;}
              .FormDataC {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center;}
              .FormDataR {color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: right;}
              .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif;}
              .FormNumText {font-size: small; font-weight: bold; font-family: arial, helvetica, sans-serif;}
              .FormAttention {font-size: medium; font-weight: bold; font-family: helvetica;}
              .FormText {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTextR {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: right;}
              .FormTextC {font-size: small; font-weight: normal; font-family: arial, helvetica, sans-serif; text-align: center;}
              .FormEMText {font-size: medium; font-style: italic; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .FormULText {font-size: medium; text-decoration: underline; font-weight: normal; font-family: arial, helvetica, sans-serif;}
              .SmallFormText {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .SmallFormTextR {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: right;}
              .SmallFormTextC {font-size: xx-small; font-family: arial, helvetica, sans-serif; text-align: center;}
              .MedSmallFormText {font-size: x-small; font-family: arial, helvetica, sans-serif; text-align: left;}
              .FormTitle {font-size: medium; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle1 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; border-top: black thick solid;}
              .FormTitle2 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .FormTitle3 {font-size: small; font-family: arial, helvetica, sans-serif; font-weight: bold; padding-top: 2em; padding-bottom: 1em;}
              .SectionTitle {font-size: small; text-align: left; font-family: arial, helvetica, sans-serif; 
              		font-weight: bold; border-top: gray thin solid; border-bottom: gray thin solid;}
              .FormName {font-size: large; font-family: arial, helvetica, sans-serif; font-weight: bold;}
              .CheckBox {text-align: center; width: 5px; cell-spacing: 0; padding: 0 3 0 3; border-width: thin; border-style: solid;  border-color: black:}
              body {background: white;}
      </style></head><body>SEC Form 3 
   <table width="100%" border="0" cellspacing="0" cellpadding="4"><tr><td width="20%" colspan="2" valign="top" align="center" class="FormName">FORM 3</td><td rowspan="1" width="60%" valign="middle" align="center"><span class="FormTitle">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span><br><span class="MedSmallFormText">Washington, D.C. 20549</span><br><br><span class="FormTitle">INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES</span><br><br><span class="MedSmallFormText">Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934</span><br><span class="MedSmallFormText">or Section 30(h) of the Investment Company Act of 1940</span></td><td rowspan="1" width="20%" valign="top" align="center"><table width="100%" border="1" summary="OMB Approval Status Box"><tr><td class="FormTextC">OMB APPROVAL</td></tr><tr><td><table width="100%" border="0" summary="OMB Interior Box"><tr><td class="SmallFormText" colspan="3">OMB Number:</td><td class="SmallFormTextR">3235-0104</td></tr><tr><td class="SmallFormText" colspan="4">Estimated average burden</td></tr><tr><td class="SmallFormText" colspan="3">hours per response:</td><td class="SmallFormTextR">0.5</td></tr></table></td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><tr><td rowspan="3" width="30%" valign="top"><span class="MedSmallFormText">1. Name and Address of Reporting Person<sup>*</sup></span><table border="0" width="100%"><tr><td><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0002054519">Siragusa Thomas</a></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(Last)</td><td width="33%" class="MedSmallFormText">(First)</td><td width="33%" class="MedSmallFormText">(Middle)</td></tr></table><table border="0" width="100%"><tr><td><span class="FormData">C/O GROVE COLLABORATIVE HOLDINGS, INC.</span></td></tr><tr><td><span class="FormData">1301 SANSOME STREET</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Street)</span><table border="0" width="100%"><tr><td width="33%"><span class="FormData">SAN FRANCISCO</span></td><td width="33%"><span class="FormData">
				CALIFORNIA
			</span></td><td width="33%"><span class="FormData">94111</span></td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" class="MedSmallFormText">(City)</td><td width="33%" class="MedSmallFormText">(State)</td><td width="33%" class="MedSmallFormText">(Zip)</td></tr></table><hr width="98%"><table border="0" width="100%"><tr><td width="33%" colspen="3"><span class="FormData">UNITED STATES</span></td></tr></table><hr width="98%"><span class="MedSmallFormText">(Country)</span></td><td rowspan="3" width="15%" valign="top"><span class="MedSmallFormText">2. Date of Event Requiring Statement
         (Month/Day/Year)</span><br><span class="FormData">02/18/2025</span></td><td valign="top" colspan="2"><span class="MedSmallFormText">3. Issuer Name <b>and</b> Ticker or Trading Symbol
      </span><br><a href="/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001841761">Grove Collaborative Holdings, Inc.</a>
     [ <span class="FormData">GROV</span> ]
   </td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">3a. Foreign Trading Symbol
		 <br></span></td><td valign="top"><span class="MedSmallFormText">5. If Amendment, Date of Original Filed
         (Month/Day/Year)</span><br><span class="FormData">03/06/2025</span></td></tr><tr><td rowspan="1" width="30%" valign="top"><span class="MedSmallFormText">4. Relationship of Reporting Person(s) to Issuer
      </span><br><span class="MedSmallFormText">(Check all applicable)</span><table border="0" width="100%"><tr><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">Director</td><td width="15%" align="center"></td><td width="35%" class="MedSmallFormText">10% Owner</td></tr><tr><td align="center"><span class="FormData">X</span></td><td class="MedSmallFormText">Officer (give title below)</td><td align="center"></td><td class="MedSmallFormText">Other (specify below)</td></tr><tr><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue">CFO</td><td width="15%" align="center"></td><td width="35%" align="left" style="color: blue"></td></tr></table></td><td valign="top"><span class="MedSmallFormText">6. Individual or Joint/Group Filing (Check Applicable Line)
      </span><table border="0" width="100%"><tr><td width="15%" align="center"><span class="FormData">X</span></td><td width="85%" class="MedSmallFormText">Form filed by One Reporting Person</td></tr><tr><td width="15%" align="center"></td><td width="85%" class="MedSmallFormText">Form filed by More than One Reporting Person</td></tr></table></td></tr></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="4" align="center" class="FormTextC"><b>Table I - Non-Derivative Securities Beneficially Owned</b></th></tr><tr><th width="44%" valign="top" align="left" class="MedSmallFormText">1. Title of Security (Instr. 
      4)
   </th><th width="19%" valign="top" align="left" class="MedSmallFormText">2. 
      Amount of Securities Beneficially Owned (Instr. 
      4)
   </th><th width="11%" valign="top" align="left" class="MedSmallFormText">3. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="26%" valign="top" align="left" class="MedSmallFormText">4. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr></thead><tbody><tr><td align="left"><span class="FormData">Class A Common Stock</span><span class="FootnoteData"><sup>(1)</sup></span></td><td align="center"><span class="FormData">29,831</span><span class="FootnoteData"><sup>(2)</sup></span><span class="FootnoteData"><sup>(3)</sup></span></td><td align="center"><span class="FormData">D</span></td><td align="left"></td></tr></tbody></table><table width="100%" border="1" cellspacing="0" cellpadding="4"><thead><tr><th width="100%" valign="top" colspan="8" align="center" class="FormTextC"><b>Table II - Derivative Securities Beneficially Owned</b><br><b>(e.g., puts, calls, warrants, options, convertible securities)</b></th></tr><tr><th width="35%" valign="top" rowspan="2" align="left" class="MedSmallFormText">1. Title of Derivative Security (Instr. 
      4)
   </th><th width="9%" valign="top" colspan="2" align="left" class="MedSmallFormText">2. Date Exercisable and Expiration Date 
      (Month/Day/Year)</th><th width="26%" valign="top" colspan="2" align="left" class="MedSmallFormText">3. Title and Amount of Securities Underlying Derivative Security (Instr. 
      4)
   </th><th width="7%" valign="top" rowspan="2" align="left" class="MedSmallFormText">4. Conversion or Exercise Price of Derivative Security
   </th><th width="8%" valign="top" rowspan="2" align="left" class="MedSmallFormText">5. Ownership Form: Direct (D) or Indirect (I) (Instr. 
      5)
   </th><th width="15%" valign="top" rowspan="2" align="left" class="MedSmallFormText">6. Nature of Indirect Beneficial Ownership (Instr. 
      5)
   </th></tr><tr><th width="4%" valign="bottom" align="center" class="MedSmallFormText">Date Exercisable</th><th width="5%" valign="bottom" align="center" class="MedSmallFormText">Expiration Date</th><th width="20%" valign="bottom" align="center" class="MedSmallFormText">Title</th><th width="6%" valign="bottom" align="center" class="MedSmallFormText">Amount or Number of Shares</th></tr></thead></table><table border="0" width="100%"><tr><td class="MedSmallFormText"><b>Explanation of Responses:</b></td></tr><tr><td class="FootnoteData">1. This Form 3/A is being filed solely to report 780 shares of Class A Common Stock that were inadvertently omitted from the reporting person's original Form 3 filed on 03/06/2025. All other holdings originally reported remain unchanged.</td></tr><tr><td class="FootnoteData">2. This amount includes 780 shares which vest upon the achievement of the following price conditions, if met prior to the tenth anniversary of the closing of the Business Combination which occurred on 6/16/2022: (i) 50% automatically vest if the daily volume weighted average price ("VWAP") of the shares of Class A Common Stock is greater than or equal to $62.50 per share for any 20 trading days within any 30-trading-day period; and (ii) 50% automatically vest if the daily VWAP of the shares of Class A Common Stock is greater than or equal to $75.00 per share for any 20 trading days within any 30-trading-day period, each subject to certain change-of-control provisions. (Continued in Footnote 3)</td></tr><tr><td class="FootnoteData">3. (Continuation of Footnote 2) In addition, any shares issued in exchange for RSUs or options are subject to the same vesting terms as the exchanged RSUs and options and, if the underlying RSU or option is forfeited, the corresponding shares will also be forfeited and distributed to the other security-holders of the issuer, as if immediately prior to the closing of the Issuer's business combination, on a pro rata basis.</td></tr></table><table width="100%" border="0"><tr><td width="60%"></td><td width="20%"><u><span class="FormData">/s/Barbara R Wallace, attorney-in-fact for Tom Siragusa</span></u></td><td width="20%"><u><span class="FormData">06/02/2026</span></u></td></tr><tr><td></td><td class="MedSmallFormText">** Signature of Reporting Person</td><td class="MedSmallFormText">Date</td></tr><tr><td colspan="3" class="MedSmallFormText">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td></tr><tr><td colspan="3" class="MedSmallFormText">* If the form is filed by more than one reporting person, 
                  <i>see</i>

                  Instruction 
                  5

                  (b)(v).</td></tr><tr><td colspan="3" class="MedSmallFormText">** Intentional misstatements or omissions of facts constitute Federal Criminal Violations 
                  <i>See</i>

                  18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td></tr><tr><td colspan="3" class="MedSmallFormText">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, 
                  <i>see</i>

                  Instruction 6 for procedure.</td></tr><tr><td colspan="3" class="MedSmallFormText"><b>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</b></td></tr><tr><td colspan="3" class="MedSmallFormText"><b>* Form 3: SEC 1473 (03-26)</b></td></tr></table></body></html>
